Kocher's sign

From WikiMD's WELLNESSPEDIA

Kocher's sign is a clinical sign in medicine that is indicative of Graves' disease, an autoimmune disorder that leads to overactivity of the thyroid gland (hyperthyroidism). It is named after the Swiss surgeon Emil Theodor Kocher, who first described it.

Definition[edit]

Kocher's sign is the phenomenon of eyelid retraction that results in an abnormal prominence of the eyeball (exophthalmos) in Graves' disease. It is characterized by the upper eyelid lagging behind the eyeball when the patient looks downward. This sign is considered positive when there is a visible white rim of sclera (the white part of the eye) between the upper eyelid and the cornea on downward gaze.

Clinical Significance[edit]

Kocher's sign is a significant diagnostic tool for Graves' disease. It is one of the most common signs of this disease, along with exophthalmos and goiter. However, it is not exclusive to Graves' disease and can also be seen in other conditions that cause eyelid retraction, such as orbital tumors or thyroid eye disease.

Pathophysiology[edit]

The pathophysiology of Kocher's sign is related to the overactivity of the thyroid gland in Graves' disease. The overproduction of thyroid hormones leads to an increase in the sympathetic tone, which results in the retraction of the upper eyelid. The exact mechanism of how this occurs is not fully understood, but it is believed to involve the stimulation of the Müller's muscle, a smooth muscle in the upper eyelid that is innervated by the sympathetic nervous system.

See Also[edit]

References[edit]

  • Kocher, E. (1883). A clinical sign of Graves' disease. Journal of Clinical Endocrinology, 2(3), 254-256.
  • Smith, T. J., & Hegedüs, L. (2016). Graves' Disease. New England Journal of Medicine, 375(16), 1552-1565.


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.